Dispatches from VitaFoods Europe 2013

System of embargoing press releases skews perception of nutrition studies, GOED chief says

By Hank Schultz

- Last updated on GMT

Related tags: Omega-3 fatty acid

Recent research results about the effectiveness of omega 3 fatty acids in the prevention of secondary heart attacks have been generalized to cast doubt on the value of the ingredients' overall effectiveness in cardiovascular health.  This is unfortunate, says Adam Ismail, global director of the Global Association of EPA and DHA Omega 3s (GOED).

Ismail said the way embargoed press releases concerning new studies are released to the public has changed, and results in the initial—and best remembered—stories written about these studies adopting the researchers' spin, without and opposing viewpoints. Ismail said in the case of the latest studies on secondary heart attacks released by JAMA and the New England Journal of Medicine, the headlines read: "Omega 3s don't work" without mentioning the significant confounding factors of the heavy and changing pharmaceutical regimens the patients in the studies where on. The contribution of omega 3 supplementation to these patients' overall health and risk of subsequent cardiac events was swamped by the drugs, he said.

Related news

Show more

Related products

show more

Does my Nutraceutical Need a Clinical Trial?

Does my Nutraceutical Need a Clinical Trial?

dicentra – CRO and regulatory consulting firm | 03-Aug-2020 | Technical / White Paper

The global nutraceutical industry is growing at an unprecedented rate. However, companies preparing to bring new and innovative products to the burgeoning...

Supporting cardiovascular health with probiotics

Supporting cardiovascular health with probiotics

Deerland Probiotics & Enzymes | 03-Aug-2020 | Technical / White Paper

Throughout the last decade, researchers have investigated the role of the gut microbiota in the development of cardiovascular disease. Evidence exists...

Related suppliers

Follow us


View more